These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 25139616)
1. JLK1486, a N,N-[(8-hydroxyquinoline)methyl]-substituted benzylamine analogue, inhibits melanoma proliferation and induces autophagy. Koekemoer TC; van de Venter M; Kraus JL Cell Prolif; 2014 Oct; 47(5):416-26. PubMed ID: 25139616 [TBL] [Abstract][Full Text] [Related]
2. Effect of apigenin-7-glucoside, genkwanin and naringenin on tyrosinase activity and melanin synthesis in B16F10 melanoma cells. Nasr Bouzaiene N; Chaabane F; Sassi A; Chekir-Ghedira L; Ghedira K Life Sci; 2016 Jan; 144():80-5. PubMed ID: 26656314 [TBL] [Abstract][Full Text] [Related]
3. Azelaic acid was sensitizing effect in the chemotherapeutic treatment of several melanoma cell lines. Rodriguez-Vicente J; Vicente-Ortega V; Canteras-Jordana Pigment Cell Res; 1996 Dec; 9(6):317-25. PubMed ID: 9125756 [TBL] [Abstract][Full Text] [Related]
4. Alternative responses of primary tumor cells and glioblastoma cell lines to N,N-bis-(8-hydroxyquinoline-5-yl methyl)-benzyl substituted amines: cell death versus P53-independent senescence. Kraus JL; Conti F; Madonna S; Tchoghandjian A; Beclin C Int J Oncol; 2010 Dec; 37(6):1463-70. PubMed ID: 21042714 [TBL] [Abstract][Full Text] [Related]
5. Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells. Benathan M; Alvero-Jackson H; Mooy AM; Scaletta C; Frenk E Melanoma Res; 1992 Dec; 2(5-6):305-14. PubMed ID: 1337997 [TBL] [Abstract][Full Text] [Related]
6. Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence. Marchal JA; Carrasco E; Ramirez A; Jiménez G; Olmedo C; Peran M; Agil A; Conejo-García A; Cruz-López O; Campos JM; García MÁ Drug Des Devel Ther; 2013; 7():1301-13. PubMed ID: 24194639 [TBL] [Abstract][Full Text] [Related]
7. Novel Amide Derivatives as Potent Tyrosinase Inhibitors; In-vitro, In-vivo Antimelanogenic Activity and Computational Studies. Ali A; Ashraf Z; Rafiq M; Kumar A; Jabeen F; Lee GJ; Nazir F; Ahmed M; Rhee M; Choi EH Med Chem; 2019; 15(7):715-728. PubMed ID: 30892163 [TBL] [Abstract][Full Text] [Related]
8. Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cells. Li Z; Jiang K; Zhu X; Lin G; Song F; Zhao Y; Piao Y; Liu J; Cheng W; Bi X; Gong P; Song Z; Meng S Cancer Lett; 2016 Jan; 370(2):332-44. PubMed ID: 26586345 [TBL] [Abstract][Full Text] [Related]
9. Organogold drug Auranofin exhibits anti-melanogenic activity in B16F10 and MNT-1 melanoma cells. Goenka S; Simon SR Arch Dermatol Res; 2020 Apr; 312(3):213-221. PubMed ID: 31501921 [TBL] [Abstract][Full Text] [Related]
10. JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation. Bruyère C; Madonna S; Van Goietsenoven G; Mathieu V; Dessolin J; Kraus JL; Lefranc F; Kiss R Transl Oncol; 2011 Jun; 4(3):126-37. PubMed ID: 21633668 [TBL] [Abstract][Full Text] [Related]
11. Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs. Thomas PD; Kishi H; Cao H; Ota M; Yamashita T; Singh S; Jimbow K J Invest Dermatol; 1999 Dec; 113(6):928-34. PubMed ID: 10594732 [TBL] [Abstract][Full Text] [Related]
12. N-(3,5-dimethylphenyl)-3-methoxybenzamide (A(3)B(5)) targets TRP-2 and inhibits melanogenesis and melanoma growth. Lee EJ; Lee YS; Hwang S; Kim S; Hwang JS; Kim TY J Invest Dermatol; 2011 Aug; 131(8):1701-9. PubMed ID: 21525883 [TBL] [Abstract][Full Text] [Related]
13. Different susceptibilities of melanoma cells to retinoic acid-induced changes in melanotic expression. Edward M; Gold JA; MacKie RM Biochem Biophys Res Commun; 1988 Sep; 155(2):773-8. PubMed ID: 3138994 [TBL] [Abstract][Full Text] [Related]
14. Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells. Tsao YT; Huang YF; Kuo CY; Lin YC; Chiang WC; Wang WK; Hsu CW; Lee CH Int J Mol Sci; 2016 Feb; 17(2):248. PubMed ID: 26901194 [TBL] [Abstract][Full Text] [Related]
15. Compounds isolated from the aerial part of Crataegus azarolus inhibit growth of B16F10 melanoma cells and exert a potent inhibition of the melanin synthesis. Mustapha N; Bzéouich IM; Ghedira K; Hennebelle T; Chekir-Ghedira L Biomed Pharmacother; 2015 Feb; 69():139-44. PubMed ID: 25661350 [TBL] [Abstract][Full Text] [Related]
16. Tyrosinase inhibition and anti-melanin generation effect of cinnamamide analogues. Ullah S; Park C; Ikram M; Kang D; Lee S; Yang J; Park Y; Yoon S; Chun P; Moon HR Bioorg Chem; 2019 Jun; 87():43-55. PubMed ID: 30856375 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells. Ullah S; Kang D; Lee S; Ikram M; Park C; Park Y; Yoon S; Chun P; Moon HR Eur J Med Chem; 2019 Jan; 161():78-92. PubMed ID: 30347330 [TBL] [Abstract][Full Text] [Related]
18. Curcumin induces permanent growth arrest of human colon cancer cells: link between senescence and autophagy. Mosieniak G; Adamowicz M; Alster O; Jaskowiak H; Szczepankiewicz AA; Wilczynski GM; Ciechomska IA; Sikora E Mech Ageing Dev; 2012 Jun; 133(6):444-55. PubMed ID: 22613224 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory Effect of Sesamolin on Melanogenesis in B16F10 Cells Determined by In Vitro and Molecular Docking Analyses. Baek SH; Kang MG; Park D Curr Pharm Biotechnol; 2020; 21(2):169-178. PubMed ID: 31612825 [TBL] [Abstract][Full Text] [Related]
20. Effects of C2-ceramide on the Malme-3M melanoma cell line. Han WS; Yoo JY; Youn SW; Kim DS; Park KC; Kim SY; Kim KH J Dermatol Sci; 2002 Oct; 30(1):10-9. PubMed ID: 12354415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]